129 related articles for article (PubMed ID: 16436743)
1. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection.
Hamelin ME; Prince GA; Boivin G
Antimicrob Agents Chemother; 2006 Feb; 50(2):774-7. PubMed ID: 16436743
[TBL] [Abstract][Full Text] [Related]
2. Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice.
Hamelin ME; Prince GA; Gomez AM; Kinkead R; Boivin G
J Infect Dis; 2006 Jun; 193(12):1634-42. PubMed ID: 16703506
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model.
Hamelin ME; Gagnon C; Prince GA; Kiener P; Suzich J; Ulbrandt N; Boivin G
Antiviral Res; 2010 Oct; 88(1):31-7. PubMed ID: 20619294
[TBL] [Abstract][Full Text] [Related]
4. The prophylactic administration of a monoclonal antibody against human metapneumovirus attenuates viral disease and airways hyperresponsiveness in mice.
Hamelin ME; Couture C; Sackett M; Kiener P; Suzich J; Ulbrandt N; Boivin G
Antivir Ther; 2008; 13(1):39-46. PubMed ID: 18389897
[TBL] [Abstract][Full Text] [Related]
5. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies.
Alvarez R; Harrod KS; Shieh WJ; Zaki S; Tripp RA
J Virol; 2004 Dec; 78(24):14003-11. PubMed ID: 15564507
[TBL] [Abstract][Full Text] [Related]
6. Immune response and alteration of pulmonary function after primary human metapneumovirus (hMPV) infection of BALB/c mice.
Darniot M; Petrella T; Aho S; Pothier P; Manoha C
Vaccine; 2005 Aug; 23(36):4473-80. PubMed ID: 15927322
[TBL] [Abstract][Full Text] [Related]
7. Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child.
Shachor-Meyouhas Y; Ben-Barak A; Kassis I
Pediatr Blood Cancer; 2011 Aug; 57(2):350-1. PubMed ID: 21671370
[No Abstract] [Full Text] [Related]
8. [Toll-like receptors expression in the lungs of human metapneumovirus infected mice and the effects of polyI:C on viral infection].
Dou Y; Zhao Y; Zhang ZY; Zhao XD
Bing Du Xue Bao; 2010 Jan; 26(1):1-7. PubMed ID: 20329551
[TBL] [Abstract][Full Text] [Related]
9. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients.
Safdar A
Bone Marrow Transplant; 2008 Apr; 41(8):707-8. PubMed ID: 18347567
[No Abstract] [Full Text] [Related]
10. Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG.
Kitanovski L; Kopriva S; Pokorn M; Dolničar MB; Rajić V; Stefanović M; Jazbec J
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e311-3. PubMed ID: 23669731
[TBL] [Abstract][Full Text] [Related]
11. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.
Raza K; Ismailjee SB; Crespo M; Studer SM; Sanghavi S; Paterson DL; Kwak EJ; Rinaldo CR; Pilewski JM; McCurry KR; Husain S
J Heart Lung Transplant; 2007 Aug; 26(8):862-4. PubMed ID: 17692793
[TBL] [Abstract][Full Text] [Related]
12. Effect of NMSO3 treatment in a murine model of human metapneumovirus infection.
Spetch L; Bowlin TL; Casola A
J Gen Virol; 2008 Nov; 89(Pt 11):2709-2712. PubMed ID: 18931066
[TBL] [Abstract][Full Text] [Related]
13. Human metapneumovirus.
Deffrasnes C; Hamelin ME; Boivin G
Semin Respir Crit Care Med; 2007 Apr; 28(2):213-21. PubMed ID: 17458775
[TBL] [Abstract][Full Text] [Related]
14. Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus.
Hamelin MÈ; Couture C; Sackett MK; Boivin G
J Gen Virol; 2007 Dec; 88(Pt 12):3391-3400. PubMed ID: 18024909
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
Bonney D; Razali H; Turner A; Will A
Br J Haematol; 2009 Jun; 145(5):667-9. PubMed ID: 19344395
[No Abstract] [Full Text] [Related]
16. Outcomes of severe human metapneumovirus-associated community-acquired pneumonia in adults.
Choi SH; Hong SB; Huh JW; Jung J; Kim MJ; Chong YP; Kim SH; Sung H; Koo HJ; Do KH; Lee SO; Lim CM; Kim YS; Woo JH; Koh Y
J Clin Virol; 2019 Aug; 117():1-4. PubMed ID: 31128379
[TBL] [Abstract][Full Text] [Related]
17. Replication and pathogenicity of attenuated human metapneumovirus F mutants in severe combined immunodeficiency mice.
Yu CM; Li RP; Chen X; Liu P; Zhao XD
Vaccine; 2012 Jan; 30(2):231-6. PubMed ID: 22085552
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats.
Hamelin ME; Yim K; Kuhn KH; Cragin RP; Boukhvalova M; Blanco JC; Prince GA; Boivin G
J Virol; 2005 Jul; 79(14):8894-903. PubMed ID: 15994783
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice.
Lê BV; Jandrot-Perrus M; Couture C; Checkmahomed L; Venable MC; Hamelin MÈ; Boivin G
J Gen Virol; 2018 Oct; 99(10):1367-1380. PubMed ID: 30102144
[TBL] [Abstract][Full Text] [Related]
20. [Apnea as a presenting symptom in human metapneumovirus infection].
Jofré M L; Luchsinger F V; Zepeda F G; Rojas C A; Muñoz A A
Rev Chilena Infectol; 2007 Aug; 24(4):313-8. PubMed ID: 17728921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
